1. Home
  2. PRQR vs AMTX Comparison

PRQR vs AMTX Comparison

Compare PRQR & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.04

Market Cap

166.8M

Sector

Health Care

ML Signal

N/A

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

N/A

Current Price

$0.93

Market Cap

134.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PRQR
AMTX
Founded
2012
2005
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
166.8M
134.2M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
PRQR
AMTX
Price
$1.04
$0.93
Analyst Decision
Strong Buy
Buy
Analyst Count
9
4
Target Price
$7.56
★ $12.39
AVG Volume (30 Days)
747.5K
★ 1.7M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.98
EPS
★ N/A
N/A
Revenue
N/A
★ $77,194,000.00
Revenue This Year
$15.20
$31.48
Revenue Next Year
N/A
$32.40
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 174.60
52 Week Low
$1.11
$1.01
52 Week High
$2.49
$3.80

Technical Indicators

Market Signals
Indicator
PRQR
AMTX
Relative Strength Index (RSI) 31.35 31.88
Support Level N/A N/A
Resistance Level $1.99 $1.85
Average True Range (ATR) 0.11 0.16
MACD -0.02 -0.04
Stochastic Oscillator 1.20 0.00

Price Performance

Historical Comparison
PRQR
AMTX

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: